AI chatbot tested for brain tumor decisions – study pulled
NCT ID NCT06163664
First seen Jan 19, 2026 · Last updated Apr 23, 2026 · Updated 13 times
Summary
This study aimed to see if using ChatGPT could help patients recently diagnosed with vestibular schwannoma (a non-cancerous brain tumor) feel less confused and more satisfied with their treatment choices. Researchers planned to compare decision-making scores between a group trained to use ChatGPT and a group that did not use it. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR SCHWANNOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.